Sharp Phillip A (CIK 0001226295)

Latest company ownership

Shares held
266,899
Last filed at
Dec 22, 2020
Confidence Score
49.8
2025Q4
Confidence Score History
2014Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 23, 2025 Jan 24, 2025 ALNYLAM PHARMACEUTICALS, INC. Director Sell 32.5 -11,250 -4.04% ✓ $3.1M
Feb 29, 2024 Mar 1, 2024 ALNYLAM PHARMACEUTICALS, INC. Director Sell 20.0 -30,000 -10.10% ✓ $4.5M
Aug 15, 2022 Aug 17, 2022 ALNYLAM PHARMACEUTICALS, INC. Director Sell 18.8 -33,670 -11.20% ✓ $7.8M
Feb 9, 2022 Feb 11, 2022 ALNYLAM PHARMACEUTICALS, INC. Director Sell 20.0 -30,000 -10.10% ✓ $4.5M
Nov 25, 2020 Nov 30, 2020 ALNYLAM PHARMACEUTICALS, INC. Director Sell 20.0 -30,000 -10.10% ✓ $3.7M
Feb 12, 2020 Feb 13, 2020 ALNYLAM PHARMACEUTICALS, INC. Director Sell 20.0 -30,000 -10.10% ✓ $3.9M
Nov 18, 2019 Nov 20, 2019 ALNYLAM PHARMACEUTICALS, INC. Director Sell 27.5 -15,000 -5.32% ✓ $1.4M
Apr 15, 2019 Apr 17, 2019 ALNYLAM PHARMACEUTICALS, INC. Director Sell 27.5 -15,000 -5.32% ✓ $1.3M
Mar 13, 2018 Mar 14, 2018 ALNYLAM PHARMACEUTICALS, INC. Director Sell 27.5 -15,000 -5.32% ✓ $2.2M
Mar 9, 2018 Mar 13, 2018 ALNYLAM PHARMACEUTICALS, INC. Director Sell 27.5 -15,000 -5.32% ✓ $1.9M
Feb 1, 2017 Feb 3, 2017 ALNYLAM PHARMACEUTICALS, INC. Director Sell 26.3 -25,000 -8.56% ✓ $995.1K
Jan 25, 2017 Jan 27, 2017 ALNYLAM PHARMACEUTICALS, INC. Director Sell 30.0 -15,000 -5.32% ✓ $569.3K
Jan 18, 2017 Jan 20, 2017 ALNYLAM PHARMACEUTICALS, INC. Director Sell 30.0 -15,000 -5.32% ✓ $567.5K
Dec 4, 2015 Dec 4, 2015 ALNYLAM PHARMACEUTICALS, INC. Director Sell 20.0 -30,000 -10.10% ✓ $3.3M
Jul 9, 2014 Oct 15, 2014 ALNYLAM PHARMACEUTICALS, INC. Director Sell 8.8 -110,000 -24.34% ✓ $9.4M